throbber
Fluorescein Binding to Normal Human Serum Proteins
`Demonstrated by Equilibrium Dialysis
`
`Wei)", Li, M O, Joh n II. Rockey, M D, PhD
`
`• The bindil'lg of "uorlleein to normal
`human •• rlJm proteins In 8 physiologic
`.olvent a' 37 ' C Vl' at me .. ured by equllib·
`rlum dla'y. I,. Human ,.r um contained
`3.28 X 10 - ~ M concentration Iluorascein(cid:173)
`binding .. II ••. w llh an average association
`con. tant a' 37 "C 01 0 .54 X IO'M" . The
`percentage of lotal flu orescein bound by
`human • • rum pro teins ranged Irom 83""
`10 53% when the total fluorescein con(cid:173)
`cenlraUo n ra nged hom 6.9 x 10-· to
`6 .2 x 10- ~ M .
`(Arch Opllthalmo/1982 ;100:4M-487)
`
`F luorescein has been widely used as
`a t racer to test the permeability of
`the blood-ocular barrier
`for
`two
`decades. U Although seve ral studies
`have been carried out on the binding
`of fluorescein to isolated serum albu(cid:173)
`min, whether fluorescein is substan(cid:173)
`tially bou nd to any plasma protein
`after intravenous injection in man
`remains controversial.z,:
`Laurenee5
`initially demonstrated
`isolated bovine serum albu(cid:173)
`that
`min showed concentration-dependent
`bi nding of fl uorescein by fluorescence
`polarization. He also reported that
`the intengity of fluorescein fluores(cid:173)
`cence dropped markedly concomitant
`with binding to bovine a lbumin (flu o-
`
`A~pl l'd for publicalion Apri l 29. 19111.
`~'rom the &heie Foye In ~l i lute, Department 0(
`l: nh·tMli ty of Pennsy lv~ni~
`OphlhalmoIOlO·.
`Medical &-hool. Philadtlphia.
`t:ye Institute,
`Repri nt rfquHu to Sche ie
`M>'ri n Cire-It. 51 ~ 39lh 51, Philatkolphia, J>A
`HII04 (Or Roekt>·).
`
`rescence quenching), and t he fluores(cid:173)
`cein absor ption lIpectrum was red
`s hifted .~ Bot h observations are fur(cid:173)
`ther evidence that nuoreseein does
`bind to bovine albumin. Andersson et
`al6 subtrequentiy demonstrated fluo(cid:173)
`rt:scein binding
`to
`isolated bovine
`albumin by equilibrium dialysis at 5
`to 30 °C.
`Recently. however. Ianacone et aP
`have studied the binding of radioac(cid:173)
`tive fluorescein using polyacrylamide
`gel electrophoresis and gel filtrat ion
`and have qUl!stioned whether fluores(cid:173)
`ctlin is bound in significant quantity
`to a ny plasma protein under physio(cid:173)
`logic conditions.
`A knowledge of the character of
`fluorescein bindinlt to blood proteins
`under phySiologic conditions is impor(cid:173)
`tant for an understanding of quanti(cid:173)
`fluorescence measurements,
`tative
`both in clinical diagnosis and in exper(cid:173)
`imental reSt!arch. We therefore have
`reexamined thi s question using eq ui(cid:173)
`librium dialysis, a classic method
`firmly established on thermodynamic
`theory t hat is well suited to study
`small ligand binding to protei n s.I. I~
`Fluorescein binding to human serum
`proteins at 37 °C in a physiologic
`solvent was measu red ins tead of bind(cid:173)
`ing to isolated bovine albu min at low
`temperatures. Substantial concentra(cid:173)
`tion-dependent binding of low affinity
`was observed t hroughout a wide range
`of fluorescein concentrations.
`MATERIALS AND METHODS
`Fre!lh blood was obtained (rom normal
`male \'oluntecn. Serum was used imme·
`
`cliateh' or stored at 4 'C until use. Serum
`prol('(ns were dilut('d tenfold wilh T.\·rode·,
`solut.ic," (1)11 7.4 ) for equil ibri um d ialysis.
`Fluorescein sodium IFunduscein) ..... as
`diluted with Tvro-de's );{)Iul ion to Io(h'e con·
`centralions of 12.5
`to 2,500
`mJ,!"/ 1.
`(0.3.1 x 10-' to 0.66 x to- 1M).
`F,(juilibrium d ialrsis was performed
`with specially dcsi~noo ~Ils. ('ach of which
`comprised two identiC<lI d,,~d (."Uml)art(cid:173)
`ments st'parated by a 23-mm (diameter)
`cellulose·disk dialvsis memhrane.'o.,) The
`cells "'ert immer~d in a constant·temper·
`atuN.' walcr bath at 31 ·C and rotated a t a
`s pel!Cl of 5 rpm. Thrlre J,l:roups of experi(cid:173)
`ments were carried oul. In ~roup 1. a J,!"h'cn
`concenlration of liuortscein !!Ulution (e)(.
`12.:) mjl:/ L I was dialyzed agai nst Tyrode's
`solution (or variations of dialYl>is
`lime
`from 15 minutes to 50 hours to determine
`the time required to attain equilibrium of
`liloland diffusion across the dialy~ i::l m~rn ­
`brane. In J,!"roup 2. a scri('s of roncentra·
`tio n ~ of fluoresc. .. ei n were dialp.ed a.gainst
`Trrooe's solution alone to dct('rminc the
`amount of dye hound b~' thel;ellulose mem(cid:173)
`brane as a function of the free fluorescein
`eon~n l rati on at equ ilibrium. In I(roup 3,
`the series of concentrations of fluorescein
`solutions w('re dia!ywd a)(ainst the 1:10
`liilutl!Cl serum. The dial.\·sis was terminated
`after 50 hours in experimental groups 2
`and 3. All cells in the t hree Krou))!; were
`run in duplicate. T he optical density of the
`fluorescein in the nonprotein compartment
`was measured at }o. 490 nm with a speoetro(cid:173)
`photomeler (Zeiss PMQ II) usin)( a 10-mm
`path-Ienjl;th eell. The molar extinction
`cot'fJicient (cl of lI uorescei n at 490 nm was
`determinE'd to be 8.6 x 10". The data of the
`group 3 experiments (dialysis of Ruores(cid:173)
`eein a)(ainst serum proteins) were cor·
`reeled for lijl;lInd binding by t he (t'lI ul~
`dialysis membranes with
`the data of
`eXlW"rimenlal Kroup 2. Protein-bou nd
`
`4a.
`
`Ar ch Ophihaimol-Vol 100, Mal ch 1982
`
`Equilibrium DialysiB-Li & Rockey
`
`Apotex v. Abraxis -IPR2018-00152, Ex. 1007, p.OI of4
`
`

`

`'00
`
`•
`" ~
`~ 50
`
`~
`"
`
`•
`
`~ (
`
`-,
`
`-.
`
`-,
`
`-.
`
`-,
`
`,.
`
`..
`
`.<2
`
`"
`
`Time, I\(
`Fig 1.-Time roquired to att ain equilibrium 01 tluorescein dilfu ~iQf1
`across dialysis membrane in ab scnce of sorum proteins. Perc enl of
`tota i lluorescein present in two compartments of equilibrium dialysis
`cell (upper curve, initial fluorescein solution side : lower curve, initial
`solvent side) is plotted against dialysis time
`
`-.
`
`l og F,
`Fig 2. - Concenlralion-dependent billdillg of fluorescein by equilib(cid:173)
`rium dialysis cell membrana. datermined in absence of serum
`protein s_ Log8rithm,o of membr8ne-bo • .md fluorescein (log F ... ) is
`plotted as IUnl;tion of the l ogarilhm,~ of free fluorescein CanCenlr8-
`tion (log F,) at equilibrium. Data were litted to straight line by method
`of teast squares.
`
`F ig 3. - Bindinll of tluoroscoin by human serum proteins al 37 · C,
`measured by equilibrium dialysis. l ogarithm,o of p rotein·bound
`Uoorescein concentra tion (corrected l or lIuoroscei" bound to the
`dietys;a m&mbranel, too F •. is plotted as function of tooarithm,o of
`free lIuarescein concer'ltra1ion, log F" at equilibrium. E)(perimen18'
`curve (solid line), measured with se'l,Im protein diluted 1: 10 in
`Tyrode's soluHon. has been cOtrected lor dilution (binding by
`undiluted serum prOleins) in upper curve (broken line).
`
`Fig 4.-Equilibrium dialysis data of Fig 3 presen ted in terms of
`Sca tc"ard plot where r is amoun t 01 fluorescein bound by protein
`and c is free lIuorescein concentration Method of least squares
`was usad to obtain basHit straight line.
`
`-,
`
`-.
`
`-,
`
`-,
`
`-.
`
`log F,
`
`-,
`
`•
`
`b
`X
`0
`
`•
`
`•
`
`•
`
`2
`
`0
`
`•
`
`,
`
`Arch Dphthaimol-Yol 100. March 1982
`
`Equilibrium Dialysis -Li & Rockey
`
`485
`
`Apotex v. Abraxis - lPR20 18-00 152, Ex. 1007, p.02 of 4
`
`

`

`iluore!l('('in IF.) was obtained from the
`fol1owin)l: rellilions hip:
`
`P. -F, -Fr-P • •
`where F, is the total r:on~nt ra.tion or Huo_
`reo<cein, Fr is the concentration of free fluo'
`rescein at equilibrium, and p ... is t he Huo,
`r~!S(."t'in bound by the dialysis cell memo
`brane.
`
`RESULTS
`
`The time required to obtain e(juilib(cid:173)
`rium of fluoresce in diffusion across
`the dialysis membrane separating t he
`two compartments of the equ ilibrium
`dialysis cell, determined in the ):.l:roup
`1 experiments, was 50 hours (Fig I),
`Therefore, all equilibrium dialysis
`experiments of fl uorescein against
`serum proteins were continued for 50
`hours or longer. The amount of fluo(cid:173)
`rescein hound by the dialysis mem(cid:173)
`brane. plotted against the free fluo(cid:173)
`rescein concentration at e(juilibrium.
`determined
`in the gr(XJP 2 experi(cid:173)
`ments. is sho ... ·n in Fig 2. The binding
`to the cellulose membrane was con(cid:173)
`centration dependent. This cu rve was
`uSt.'tI
`in calculating protein-bound
`fluorescei n (F~) from the experimen(cid:173)
`tal group 3 results, where t he total
`fluorescein (F,) a nd free fluorescein
`(Fr) eoncentrationll at Ctluilibri um
`were known.
`In Fig 3, the logarithm of the pro(cid:173)
`tein-bou nd fl uoresctin concentration
`(loglt F ,), corrected for the dye bound
`to the artificial membrane. is plotted
`against that of the free fluorescein
`concentration. The flatness of the
`binding cune at the highest free
`fluorescein concentrations indicated
`that protein fluo rescein-bi nding site
`saturation had been obtained (Pig 3).
`The experimental data were deter(cid:173)
`mined using iflnfotd-di luted human
`serum proteins. To approxi mate t he in
`vivo situation,
`the :second (upper)
`curve of Fig :.I shows t he data replot(cid:173)
`led for binding to undiluted serum
`proteins, This
`curve
`is
`simply
`obta ined because the free fluorescein
`concentration (P,) determines only
`the fraction of available binding sites
`occupied by fl uorescein; the amount of
`fluor escein bound at a given free
`fl uorescein concentration is a simple
`linear fun ction of the concentration of
`available binding sites (eg. proteins)
`(see below, I<'ig 4).
`The maximal and mi nimal fractio ns
`of the lotal
`fl uorescein bound by
`undiluted serum proteins at 37 °C
`throughout the range of frce fluores(cid:173)
`cein concentrations examined are giv~
`en in the Table, The molar concentra(cid:173)
`tion of fluorescein-binding !!lites in
`undiluted hu man serum, determined
`
`Pereenl age 01 TOl al Fluorescein Bound b~ Undiluted $arom P,oteins at t oweSI
`and Higheat Free Fluoffilseein Concentrations Measured
`
`Total
`
`'"
`15.9 X iO-'
`15.2 X 10- '
`
`frn
`'"
`
`t.2 X 10 •
`2.~ X 10"
`
`.~'"
`IF,)
`5.T x io-'
`3.3 X 10-'
`
`Rallo F,I " .
`X 100. ""
`
`" "
`
`from Fig 3, was 3.28 X 1O-'M,
`Binding data of Fig 3 were replotted
`in Fig 4 in the form of a Scatchard
`plot,II.lt" ric vs r. where r is the
`amount of protein-bound fl uorescein
`and c is the concentration of free
`Ouorescein. The maximum value for
`r (n) was arbitrarily chosen as 2, so
`that the association constant (KeJ is
`given hy the reciprocal or the freu-dye
`concentration at r - I (half of the
`binding sites of the proteins were
`occupied by fl uorescein), as obtained
`from the relationship K." r( n - r )-'
`c- I . " " The average intrinsic associa(cid:173)
`tion oonstant (K.) of human serum
`proteins in a physiologic solvent at 37
`°C for fl uorescei n was 0.54 X I ~M -'.
`
`COMMENT
`
`The present results of equilibrium
`dialysis demonstrate that in a physio(cid:173)
`logie solvent at 37 °C, substantial
`binding of
`fl uorescein
`to human
`serum proteins aceurs throughout a
`wide range of fluorescein concentra(cid:173)
`tions, even thou~h the association is
`of low affinity. The appropriateness of
`equ ilibrium dialysis for evaluating
`fluorescein bi nding under physiologic
`conditions hall been questioned by
`lanaeone et aiT because of the long
`time requi red to obtain equilibrium.
`This misu nderstanding has occurred
`because the time required fo r free
`ligand to reach equi librium across the
`artificial dialysis membrane (eg. 50
`hours) has not been d ifferentiated
`from the forwa rd rale constant for
`fluo rescein-protein association, ob(cid:173)
`tained when fluoresce i n
`is added
`dir~t1y to a protein solution, which is
`limited on ly by the rate of diffusion of
`fluoresce in in free sol u tion.~lf The
`artificial
`semipermeable
`dialysis
`membrane is only used so that an
`unambi~uou s measu re of the free
`ligand concentration may be obtained.
`The technique is en tirely appropriate
`for measurements of equilibrium
`thermodynam ic parameters of asso(cid:173)
`ciation of rapidly
`interacting sys(cid:173)
`tems." "
`Gel filtration and polyacrylamide
`gel electrophoresis,! however, may not
`be appropriate techniques to measure
`associations of
`fluorescein -protein
`
`low affinity. In both techniques, f1uo(cid:173)
`rescein'protein complexes are contin(cid:173)
`uously bei ng separated from
`free
`fluorescein because of their differen(cid:173)
`tial migration rates. This factor is
`particularly
`true
`in gel filt ration,
`where fluorescein-protein complexes,
`because of their larger size, arc con (cid:173)
`tinuously being transferred into sol·
`ven t that contains no free fluorescei n .
`This process is equivalent to dialyting
`the
`fl uorescei n.protein
`com plexes
`against an infini te volume of soillent
`and is an effectille way to dissociate
`ligand-protein com plexes of low affin·
`ity. These tcehniques will not measure
`the extent of binding of fiuo res«in t<l
`blood proteins that oc<:urs in the pres(cid:173)
`ence of high concentrations of free
`fl uorescein.
`The concentration of fluorescein(cid:173)
`binding lIites in serum was deter(cid:173)
`mined to be 3.28 x 1O-3M. The normal
`concentration of albumin in human
`serum
`is 0.65 x 1O-3M.u
`Isolated
`bovine serum albumin has been
`reported to have three binding sites
`per molecu l e.~ The ratio for bound
`l1uores~in to human serum albumin
`of 5 (3.28:0.65) indicates either that
`human serum albumin has five fl uo(cid:173)
`rescein·binding sites per molecule or,
`more likely. that other serum proteins
`(eg, low-affinity IgG immunoglobu(cid:173)
`Ii ns) also bind fl uorescein under phys(cid:173)
`iologic conditions. A knowledge 01 the
`fluorescein bi nding by blood protein s
`of substantially different size and dif·
`fusion rates wou ld be of importance
`fo r a oomplete picture in quantitative
`st udies of blood-ocular permeability
`changes.
`A knowledge of the extent of flu()(cid:173)
`rescei n binding to proteins at differ (cid:173)
`en t free fluorescein concentrations
`also is necCMary when blood flu ores(cid:173)
`cein levels are measured ftuorometri (cid:173)
`cally, since t hese data must be cor(cid:173)
`rected for the fluor escence quenching
`fl uorescein if a true
`of the bound
`measure of total fluorescein content is
`to be obtained by this method.
`The find ing that a substantial frac (cid:173)
`tion of the total injected fl ooresce in is
`bound at low affi nity by human blood
`proteins in a physiologic solvent at
`3'7 "C is eonsistent with clinical obser (cid:173)
`vations. The laminar flow seen in reti-
`
`486
`
`Arc h Ophihaimol-Vol 100. March 1982
`
`Equilibrium Dialysis-li & Rocke~
`
`Apotex v. Abrax is -IPR20 18-00 152, Ex. 1007, p.03 of4
`
`

`

`nal vessels!.l' in all likelihood reflects
`fluorescein bound to proteins, as the
`protein-bound
`fluorescein diffusion
`rate will be much slower than that of
`free fluorescein. The rapid changes in
`the volumes of distribution of fl uores(cid:173)
`cein and 13lI_labeled albumin, ob(cid:173)
`served when both were injected simul(cid:173)
`taneously,!f would reflect
`the low
`association constant of fluorescein
`
`binding.
`A complete understanding of quan(cid:173)
`titative fluorescein angiography of
`the retina and vitreous fluorometry
`will require a detailed knowledge of
`the contribution of fluo rescein bind(cid:173)
`ing by blood constituents during the
`changing concentration ratios occur(cid:173)
`ring intravascularly and extravascu(cid:173)
`larly after the initial injection of the
`
`bolus of fluorescein. The present
`experimental results may be used to
`calculate the contribution of fluores(cid:173)
`cei n binding by human serum proteins
`in such studies.
`
`This study wall sup"".ted by an un~stritl-ed
`Kranl f'om Rnl-areh 10 P re_ent Bl indn .. "... Inc,
`New York. and by
`th e Hatry and Edith
`Hu~hman Re-search ~'und
`
`Raferences
`
`I. Novolmy HR. Alvi. 01..; A method of photo(cid:173)
`graphin.(t Huorescence in cireulating blood in the
`human utina. Circu/ali(l'll 1961;24:S2·SG.
`2. Wes.inp; A: tlioc~ .mical properties of Huo(cid:173)
`r."""in. in Fllmrescrin A ",,;ovraph~ 0/ the Reh·
`nil " 5 t l.oui8, CV MO$by Co. 1969. "" 13-14.
`3. LauRe K. Boyd W : Use of Huo.-.e"""in
`method in ""t .. bli.hment of di8j(n (>Si. and pr<>g(cid:173)
`nO$is of peripheral vascular disease$. A"",h
`hlp", Moo 1944;14:175-18<1 .
`4. H~ JY. Dollcry C1': Retinal iOrt txu(cid:173)
`da le.: A d inica l study by eol""r and nuor<"5(en""
`phoUllluphy. Q J M<id 19&1:33:117-1110
`5. Lauren"" DJR: A study of Ihe aboo,ption of
`dyu on bovine se rum albumin by the mdhod of
`""laTi'alion uf Hoo'h«n"". Biochem J im.
`:>1:168_180.
`6. Andersson LO, Rebnnr(lm A. F,.aker OI~
`StudicM on 'non-specific' bindillJ(: The nature of
`
`the bindinl/ or fluoresuin to bovine ""rum albu·
`min. Eur J BiocMm 1971;20:37hlSO.
`7. lanacone DC. ~'eI Mrg NT. ~·ed~.man JI..;
`Tritiated fluore!l<:ein bindinl/ to normal haman
`plasma proteins. A. rch Ophlhall'rloi 191>(1;98:1643-
`1645.
`8. Karush F. SOnenbe .... ),!: Interaction or
`homolOKOuS alkyl aulfau-s with bovine "".um
`.. lbum in. J Am Cite",&<; 1949;71:1369-1376.
`9. Hascheme)'er RH_ I-Iaschem .. yer AE: Met h(cid:173)
`od balIM on char~ or chal")i:e di~ltibution. in
`l1aschemeyu RI!. lIaschemeyer AE (edsl; I'ro(cid:173)
`tei_ A Guide toSttu/lIbJi Pltlln eol a.w Chemical
`Me1/tods. New York_John Wiley &- !;on. Inc, 197"J.
`pp 2.;4.2(;8.
`10. Karu . 1I F: The interaction of purified ant;(cid:173)
`bnd)" witb npticall)' i""merie hapten~. J Am Cite",
`$x 1%6;18;~ 19-:N26.
`II. Klotz I: Thc a pplicatio n of the law of mass
`
`action to hinding b)' pr<>teins: Interactions with
`calcium. Arch BiQ<;hem 1946;9:1Q9-111.
`12 Sea1.Chrd C. ScheinM'lI lH, A.mstr<>na(cid:173)
`SH: Physi cal chemi stry of prOl ein !(Ilution " IV.
`Thc eombinatio n or human SC rum albumin with
`ohlorid~ i"n. JAm Che", Soc 19liO;12:535-MO.
`1<1. Rockey JH: Equine anlihapt.. n antibody:
`The ~ubunih an d fragm ents of anti-/l-la<:tOl<ide
`antibody. J I::;r:p Med 1967:125:249-2'1:>.
`14. Wu WI-I , Rockey JI-I: Antivasopr~.in anti(cid:173)
`body: Chara<:teri .... tion o f high _a lfinity rabbit
`antibnd)' wilh li mited association constant hete.(cid:173)
`OI«'neil)·. BiochfmW'l' 1969;8,2719-2728.
`15. Gu}·ton AC (ed): Tnrbook oj Medical Phll~
`idOl/II. Philadtlphia. WB Saunders <A. 1976. pp
`."193-394.
`11;. Dollery CT. 1I<>d¥" JV. En~ 1 M: Studi"", of
`the .-.elinal ci",ulalion with Huoreseein. BT M,"'- J
`1962:2:1210-1215.
`
`Arch Ophthaimol-Vol 100. March 1982
`
`E.quilit)rium Di"lys is -Li & Rockey
`
`487
`
`Apotex v. Abraxis - lPR20 18-00 152, Ex. 1007, p.04 of 4
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket